H
Hermann Pavenstädt
Researcher at University of Freiburg
Publications - 220
Citations - 13441
Hermann Pavenstädt is an academic researcher from University of Freiburg. The author has contributed to research in topics: Podocyte & Medicine. The author has an hindex of 52, co-authored 194 publications receiving 11628 citations.
Papers
More filters
Journal ArticleDOI
Cell Biology of the Glomerular Podocyte
TL;DR: This review integrates recent physiological and molecular understanding of the role of podocytes during the maintenance and failure of the glomerular filtration barrier with hereditary nephrotic syndromes identified over the last 2 years.
Journal ArticleDOI
Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines
Peter Mundel,Jochen Reiser,Aimée Zúñiga Mejı́a Borja,Hermann Pavenstädt,Gary Davidson,Wilhelm Kriz,Rolf Zeller +6 more
TL;DR: The determinative steps of podocyte differentiation and process formation are studied for the first time using an inducible in vitro model and electrophysiological studies demonstrate that differentiated MPC cells respond to the vasoactive peptide bradykinin by changes in intracellular calcium concentration.
Journal ArticleDOI
Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial
Alexander Zarbock,John A. Kellum,Christoph Schmidt,Hugo Van Aken,Carola Wempe,Hermann Pavenstädt,Andreea Boanta,Joachim Gerß,Melanie Meersch +8 more
TL;DR: To determine whether early initiation of RRT in patients who are critically ill with AKI reduces 90-day all-cause mortality, a single-center randomized clinical trial of 231 critically ill patients with KDIGO stage 2 found that more patients in the early group recovered renal function by day 90.
Journal ArticleDOI
Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice
Björn Hartleben,Markus Gödel,Catherine Meyer-Schwesinger,Shuya Liu,Theresa Ulrich,Sven Köbler,Thorsten Wiech,Florian Grahammer,Sebastian J. Arnold,Maja T. Lindenmeyer,Clemens D. Cohen,Hermann Pavenstädt,Dontscho Kerjaschki,Noboru Mizushima,Andrey S. Shaw,Gerd Walz,Tobias B. Huber +16 more
TL;DR: It is postulate that constitutive and induced autophagy is a major protective mechanism against podocyte aging and glomerular injury, representing a putative target to ameliorate human glomersular disease and aging-related loss of renal function.
Journal ArticleDOI
Everolimus in patients with autosomal dominant polycystic kidney disease.
Gerd Walz,Klemens Budde,Marwan Mannaa,Jens Nürnberger,Christoph Wanner,Claudia Sommerer,Ulrich Kunzendorf,Bernhard Banas,Walter H. Hörl,Nicholas Obermüller,Wolfgang Arns,Hermann Pavenstädt,Jens Gaedeke,Martin Büchert,Christoph May,Harald Gschaidmeier,Stefan Kramer,Kai-Uwe Eckardt +17 more
TL;DR: Within the 2-year study period, everolimus slowed the increase in total kidney volume of patients with ADPKD but did not slow the progression of renal impairment [corrected].